218 related articles for article (PubMed ID: 23773596)
1. Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.
Clark AD; Griffiths UK; Abbas SS; Rao KD; Privor-Dumm L; Hajjeh R; Johnson H; Sanderson C; Santosham M
J Pediatr; 2013 Jul; 163(1 Suppl):S60-72. PubMed ID: 23773596
[TBL] [Abstract][Full Text] [Related]
2. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
Constenla D; Liu T
Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.
Griffiths UK; Clark A; Hajjeh R
J Pediatr; 2013 Jul; 163(1 Suppl):S50-S59.e9. PubMed ID: 23773595
[TBL] [Abstract][Full Text] [Related]
5. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P
Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia.
Miller MA
Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S152-9. PubMed ID: 9781750
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China.
Ning G; Yin Z; Li Y; Wang H; Yang W
Hum Vaccin Immunother; 2018 Jan; 14(1):36-44. PubMed ID: 29049002
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.
Le P; Griffiths UK; Anh DD; Franzini L; Chan W; Swint JM
Vaccine; 2015 Aug; 33(36):4639-46. PubMed ID: 26044493
[TBL] [Abstract][Full Text] [Related]
9. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
11. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
[TBL] [Abstract][Full Text] [Related]
12. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.
Zhou F; Bisgard KM; Yusuf HR; Deuson RR; Bath SK; Murphy TV
Pediatrics; 2002 Oct; 110(4):653-61. PubMed ID: 12359777
[TBL] [Abstract][Full Text] [Related]
13. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
Gargano LM; Hajjeh R; Cookson ST
Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
[TBL] [Abstract][Full Text] [Related]
14. [The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia].
Alvis Guzmán N; De La Hoz Restrepo F; Vivas Consuelo D
Rev Panam Salud Publica; 2006 Oct; 20(4):248-55. PubMed ID: 17316483
[TBL] [Abstract][Full Text] [Related]
15. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine program in Florida.
Midani S; Ayoub EM; Rathore MH
J Fla Med Assoc; 1995 Jun; 82(6):401-2. PubMed ID: 7643054
[TBL] [Abstract][Full Text] [Related]
18.
Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
Broughton EI
J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
[TBL] [Abstract][Full Text] [Related]
20. National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis.
Zhang H; Garcia C; Yu W; Knoll MD; Lai X; Xu T; Jing R; Qin Y; Yin Z; Wahl B; Fang H
BMC Med; 2021 Aug; 19(1):181. PubMed ID: 34376214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
